INO
HEALTHCAREInovio Pharmaceuticals Inc
$1.24+0.10 (+8.77%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving INO Today?
No stock-specific AI insight has been generated for INO yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$1.03$2.98
$1.24
Fundamentals
Market Cap$101M
P/E Ratio—
EPS$-1.81
Dividend Yield—
Dividend / Share—
ROE-1.8%
Profit Margin—
Debt / Equity—
Trading
Volume3.1M
Avg Volume (10D)—
Shares Outstanding81.6M
INO News
34 articles- INOVIO to Participate in Upcoming Scientific ConferencesYahoo Finance·May 8, 2026
- ACAD Q1 Earnings & Revenues Miss Estimates Despite Y/Y Sales GrowthYahoo Finance·May 7, 2026
- Madrigal Q1 Earnings Beat, MASH Drug Sales Drive Top Line, Stock UpYahoo Finance·May 7, 2026
- RXRX Q1 Loss Narrower Than Expected, Revenues Decline Y/YYahoo Finance·May 7, 2026
- RARE Q1 Loss Wider Than Expected, Sales Down Y/Y on Seasonal EffectYahoo Finance·May 6, 2026
- INOVIO to Report First Quarter Financial Results on May 13, 2026Yahoo Finance·May 1, 2026
- Pacira Q1 Earnings Miss Estimates on Higher Costs, Revenues Rise Y/YYahoo Finance·May 1, 2026
- Q32 Bio Gears Up to Report Q1 Earnings: What's in the Cards?Yahoo Finance·Apr 30, 2026
- Vertex Gears Up to Report Q1 Earnings: What Investors Can ExpectYahoo Finance·Apr 28, 2026
- CRISPR Therapeutics to Report Q1 Earnings: Is a Beat in the Cards?Yahoo Finance·Apr 27, 2026
- INBX Stock Up on Upbeat Clinical Update From Colorectal Cancer StudyYahoo Finance·Apr 23, 2026
- Viking Therapeutics Gears Up for Q1 Earnings: Here's What to ExpectYahoo Finance·Apr 21, 2026
- NKTX Stock Up on Upbeat Regulatory Update on Lead Autoimmune ProgramYahoo Finance·Apr 17, 2026
- TVTX Stock Soars on FDA Nod for Filspari in Second Kidney IndicationYahoo Finance·Apr 15, 2026
- Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc. and Certain Officers – INOGlobeNewswire Inc.·Apr 7, 2026
- DEADLINE ALERT for PSFE, INO, KD: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class ActionsGlobeNewswire Inc.·Apr 7, 2026
- Bragar Eagel & Squire, P.C. Urgently Reminds Investors that a Class Action Lawsuit Has Been Filed Against Inovio Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm Before April 7thGlobeNewswire Inc.·Apr 6, 2026
- Shareholders that lost money on Atara Biotherapeutics, Inc.(ATRA) should contact Levi & Korsinsky about pending Class Action - ATRAGlobeNewswire Inc.·Apr 6, 2026
- UNIQURE DEADLINE: ROSEN, A LEADING AND LONGSTANDING FIRM, Encourages uniQure N.V. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 13 Deadline in Securities Class Action - QUREGlobeNewswire Inc.·Apr 6, 2026
- INO FINAL DEADLINE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Inovio Pharmaceuticals Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 7 Deadline in Securities Class Action – INOGlobeNewswire Inc.·Apr 6, 2026
- Deadline Alert: Inovio Pharmaceuticals, Inc. (INO) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud LawsuitGlobeNewswire Inc.·Apr 3, 2026
- Inovio (INO) Loses 32.7% in 4 Weeks, Here's Why a Trend Reversal May be Around the CornerYahoo Finance·Apr 3, 2026
- INO FINAL DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Inovio Pharmaceuticals Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 7 Deadline in Securities Class Action – INOGlobeNewswire Inc.·Apr 2, 2026
- ROSEN, THE FIRST FILING FIRM, Encourages Trip.com Group Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - TCOMGlobeNewswire Inc.·Apr 2, 2026
- INOVIO Announces Pricing of $17.5 Million Public OfferingYahoo Finance·Apr 2, 2026
- INOVIO Announces Proposed Public OfferingYahoo Finance·Apr 2, 2026
- INOVIO to Participate in Upcoming Scientific ConferenceYahoo Finance·Apr 1, 2026
- ROSEN, THE FIRST FILING FIRM, Encourages Kyndryl Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – KDGlobeNewswire Inc.·Mar 30, 2026
- INOVIO DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Inovio Pharmaceuticals Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 7 Deadline in Securities Class Action – INOGlobeNewswire Inc.·Mar 30, 2026
- Bronstein, Gewirtz & Grossman LLC Urges Inovio Pharmaceuticals, Inc. Investors to Act: Class Action Filed Alleging Investor HarmGlobeNewswire Inc.·Mar 30, 2026
- Novo Nordisk's Awiqli Gets FDA Approval for Type II DiabetesYahoo Finance·Mar 27, 2026
- KOD Stock Soars on Promising Phase III Data for Eye Disease CandidateYahoo Finance·Mar 27, 2026
- INO DEADLINE ALERT: ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Inovio Pharmaceuticals Inc. Investors to Secure Counsel Before Important April 7 Deadline in Securities Class Action – INOGlobeNewswire Inc.·Mar 24, 2026
- Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc.and Certain Officers – INOGlobeNewswire Inc.·Mar 24, 2026
All 34 articles loaded
Price Data
Open$1.15
Previous Close$1.14
Day High$1.28
Day Low$1.13
52 Week High$2.98
52 Week Low$1.03
52-Week Range
$1.03$2.98
$1.24
Fundamentals
Market Cap$101M
P/E Ratio—
EPS$-1.81
Dividend Yield—
Dividend / Share—
ROE-1.8%
Profit Margin—
Debt / Equity—
Trading
Volume3.1M
Avg Volume (10D)—
Shares Outstanding81.6M
About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA drugs to treat and protect people from diseases associated with the human papillomavirus (HPV), cancer, and infectious diseases.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—